The long non-coding RNA PCSEAT exhibits an oncogenic property in prostate cancer and functions as a competing endogenous RNA that associates with EZH2-Reference-Cited by-同舟云学术

The long non-coding RNA PCSEAT exhibits an oncogenic property in prostate cancer and functions as a competing endogenous RNA that associates with EZH2

Published:2018-07 Issue:2 Volume:502 Page:262-268
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Yang Xiaohui,Wang Liang,Li Rong,Zhao Yuhui,Gu Yinmin,Liu Siying,Cheng Tianyou,Huang Kuohsiang,Yuan Yi,Song Dalong,Gao Shan

Funder

National Natural Science Foundation of China

National Key R&D Program of China

Hundred-Talent Program

Frontier Research Program

Chinese Academy of Sciences

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference36 articles.

1. Prostate cancer;Attard;Lancet,2015

2. Integrative clinical genomics of advanced prostate cancer;Dan;Cell,2015

3. Integrative clinical genomics of advanced prostate cancer;Robinson;Cell,2015

4. Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of for a first-line diagnostic test;Roobol;Eur. Urol.,2011

5. The mystery of "rubbish" DNA;Chang;Chin. Sci. Bull.,2016

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current landscape of exosomal non-coding RNAs in prostate cancer: Modulators and biomarkers;Non-coding RNA Research;2024-12

2. Roles of long non-coding RNA in prostate cancer pathogenesis;Clinical Genitourinary Cancer;2024-08

3. Biological functions and potential mechanisms of miR‑143‑3p in cancers (Review);Oncology Reports;2024-07-05

4. EZH2: A Critical Competing Endogenous RNA in Cancer Research - A Scoping Review;2024-04-22

5. Updated review on analysis of long non-coding RNAs as emerging diagnostic and therapeutic targets in prostate cancers;Critical Reviews in Oncology/Hematology;2024-04